The side effects of phentermine include dry mouth, unpleasant taste, diarrhea, constipation, and vomiting (find the full list of side effects here)
GLP-1 class safety monitoring should include awareness of these important risks: Pancreatitis : Patients should promptly report severe abdominal pain, with or without vomiting Gallbladder disease : Report symptoms of biliary colic or cholecystitis Acute kidney injury : Maintain adequate hydration, especially if experiencing nausea/vomiting Hypoglycemia : Increased risk when used with insulin or sulfonylureas Suicidal ideation : For patients using Wegovy or Zepbound, monitor for mood changes Patients should be counseled to report any neck swelling, difficulty swallowing, persistent hoarseness, or palpable thyroid nodules, as these warrant evaluation regardless of GLP-1 use
doi: 10.1186/s12935-024-03525-9 3 AppunniS.RubensM.RamamoorthyV.SaxenaA.TonseR.VeledarE.et al
Some users who have been off treatment and want to resume should review the guidelines for restarting semaglutide after a break , as dosing protocols may differ from the initial start
